Labetalol: Difference between revisions
No edit summary |
|||
| Line 14: | Line 14: | ||
Cardiovascular Drugs:Beta blockers | Cardiovascular Drugs:Beta blockers | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
===LABETALOL HYDROCHLORIDE injection=== | |||
'''| [[Labetalol indications and usage|Indications and Usage]]''' | '''| [[Labetalol injection indications and usage|Indications and Usage]]''' | ||
'''| [[Labetalol dosage and administration|Dosage and Administration]]''' | '''| [[Labetalol injection dosage and administration|Dosage and Administration]]''' | ||
'''| [[Labetalol dosage forms and strengths|Dosage Forms and Strengths]]''' | '''| [[Labetalol injection dosage forms and strengths|Dosage Forms and Strengths]]''' | ||
'''| [[Labetalol contraindications|Contraindications]]''' | '''| [[Labetalol injection contraindications|Contraindications]]''' | ||
'''| [[Labetalol warnings and precautions|Warnings and Precautions]]''' | '''| [[Labetalol injection warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Labetalol adverse reactions|Adverse Reactions]]''' | '''| [[Labetalol injection adverse reactions|Adverse Reactions]]''' | ||
'''| [[Labetalol drug interactions|Drug Interactions]]''' | '''| [[Labetalol injection drug interactions|Drug Interactions]]''' | ||
'''| [[Labetalol use in specific populations|Use in Specific Populations]]''' | '''| [[Labetalol injection use in specific populations|Use in Specific Populations]]''' | ||
'''| [[Labetalol overdosage|Overdosage]]''' | '''| [[Labetalol injection overdosage|Overdosage]]''' | ||
'''| [[Labetalol description|Description]]''' | '''| [[Labetalol injection description|Description]]''' | ||
'''| [[Labetalol clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Labetalol injection clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Labetalol nonclinical toxicology|Nonclinical Toxicology]]''' | '''| [[Labetalol injection nonclinical toxicology|Nonclinical Toxicology]]''' | ||
'''| [[Labetalol clinical studies|Clinical Studies]]''' | '''| [[Labetalol injection clinical studies|Clinical Studies]]''' | ||
'''| [[Labetalol how supplied storage and handling|How Supplied/Storage and Handling]]''' | '''| [[Labetalol injection how supplied storage and handling|How Supplied/Storage and Handling]]''' | ||
'''| [[Labetalol patient counseling information|Patient Counseling Information]]''' | '''| [[Labetalol injection patient counseling information|Patient Counseling Information]]''' | ||
'''| [[Labetalol labels and packages|Labels and Packages]]''' | '''| [[Labetalol injection labels and packages|Labels and Packages]]''' | ||
===LABETALOL HYDROCHLORIDE tablet=== | |||
'''| [[Labetalol tablet indications and usage|Indications and Usage]]''' | |||
'''| [[Labetalol tablet dosage and administration|Dosage and Administration]]''' | |||
'''| [[Labetalol tablet dosage forms and strengths|Dosage Forms and Strengths]]''' | |||
'''| [[Labetalol tablet contraindications|Contraindications]]''' | |||
'''| [[Labetalol tablet warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Labetalol tablet adverse reactions|Adverse Reactions]]''' | |||
'''| [[Labetalol tablet drug interactions|Drug Interactions]]''' | |||
'''| [[Labetalol tablet use in specific populations|Use in Specific Populations]]''' | |||
'''| [[Labetalol tablet overdosage|Overdosage]]''' | |||
'''| [[Labetalol tablet description|Description]]''' | |||
'''| [[Labetalol tablet clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Labetalol tablet nonclinical toxicology|Nonclinical Toxicology]]''' | |||
'''| [[Labetalol tablet clinical studies|Clinical Studies]]''' | |||
'''| [[Labetalol tablet how supplied storage and handling|How Supplied/Storage and Handling]]''' | |||
'''| [[Labetalol tablet patient counseling information|Patient Counseling Information]]''' | |||
'''| [[Labetalol tablet labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | ==Mechanism of Action== | ||
Revision as of 17:28, 5 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
For patient information about Labetalol, click here
Synonyms / Brand Names:
Overview
Labetalol (Normodyne, Trandate, fixed combination with hydrochlorothiazide: Normozyde) is an alpha-1 andbeta adrenergic blocker used to treat high blood pressure. It works by blocking these adrenergic receptors, which slows sinus heart rate, decreases peripheral vascular resistance.
It has a particular indication in the treatment of pregnancy-induced hypertension.
Category
Cardiovascular Drugs:Beta blockers
FDA Package Insert
LABETALOL HYDROCHLORIDE injection
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
LABETALOL HYDROCHLORIDE tablet
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages